Delphia (USA)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,021
| Closed | -$359K | – | 189 |
|
|
2023
Q2 | $359K | Sell |
1,021
-471
| -32% | -$166K | 0.57% | 57 |
|
|
2023
Q1 | $470K | Buy |
1,492
+757
| +103% | +$239K | 0.58% | 43 |
|
|
2022
Q4 | $212K | Buy |
+735
| New | +$212K | 0.24% | 187 |
|
|
2022
Q3 | – | Sell |
-1,667
| Closed | -$470K | – | 426 |
|
|
2022
Q2 | $470K | Sell |
1,667
-411
| -20% | -$116K | 0.32% | 96 |
|
|
2022
Q1 | $542K | Buy |
2,078
+7
| +0.3% | +$1.83K | 0.41% | 68 |
|
|
2021
Q4 | $455K | Buy |
+2,071
| New | +$455K | 0.48% | 51 |
|